Related Experiment Video
Updated: Oct 3, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Combination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral
Chiranjib Pal1, Mousumi Raha, Anirban Basu
1Immunology Division, Indian Institute of Chemical Biology, Jadavpur, Kolkata-700 032, India.
Abstract:
2-(2"-Dichloroacetamidobenzyl)-3-(3'-indolylquinoline), designated indolylquinoline derivative A, reduced the splenic and the liver parasite burdens by >93.0% in Leishmania donovani-infected hamsters, whereas sodium antimony gluconate (SAG) reduced the burdens approximately 80.0%. Complete clearance of parasitemia from the livers and spleens was noticed when infected animals received indolylquinoline derivative A plus SAG, suggesting that indolylquinoline derivative A has potential as a new agent for sole or conjunctive therapy for leishmaniasis.
Related Concept Videos
Antiprotozoal Agents
Leishmaniasis
Anthelminthic Agents

